June 12, 2023 07:16 AM EDTUpdated 10:44 AM
Pharma
Manufacturing

No­vo Nordisk ups in­vest­ment in Den­mark API man­u­fac­tur­ing fa­cil­i­ty to $2.3B

Katherine Lewin

News Reporter

Amid on­go­ing short­ages of some of its most pop­u­lar drugs, No­vo Nordisk said it is in­vest­ing $2.3 bil­lion (15.9 bil­lion Dan­ish kro­ner) to­tal to ex­pand …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Com­pass Path­ways de­lays key Phase 3 psilo­cy­bin read­outs, spurring 30% lay­offs

Am­gen makes pipeline cuts, but obe­si­ty plans re­main the fo­cus

Bris­tol My­ers ups rev­enue guid­ance again, rais­ing con­fi­dence in cost-cut­ting

Ab­b­Vie adds to T cell en­gager mo­men­tum, with EvolveIm­mune pact start­ing at $65M

Ar­genx re­ports Vyv­gart sales streak, bol­stered by launch in rare neu­ro dis­or­der

An­oth­er Paragon off­shoot inks re­verse merg­er as Jade takes Aerovate’s place

A service from the Financial Times